As new approaches with immunotherapy are rolling in to clinic in the fields of thoracic malignancies, here we would like to focus on immunotherapy. Our guest editor for this issue isProfessor Yasuhiko Nishioka, Professor and Chairman, Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, University of Tokushima Graduate School.
This issue includes the reviews regarding all useful and hopeful immunotherapies against thoracic malignancies presented above, and therefore could be helpful for the readers to understand overall immune responses against lung cancer as well as current ongoing immunotherapies. We hope that new wave of immunotherapy ultimately contribute to the health and life of patients with lung cancer or malignant mesothelioma in the near future. Please follow up on this special issue to learn the latest update for immunotherapies against thoracic malignancies.
